• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核p53蛋白优先在髓样和高级别导管性乳腺癌中积累,但在小叶性乳腺癌中很少积累。

Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.

作者信息

Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M

机构信息

Department of Tumor Pathology, Medical Academy, Szczecin, Poland.

出版信息

Am J Pathol. 1993 Mar;142(3):669-74.

PMID:8384406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1886797/
Abstract

Striking differences were found between different histological types of breast cancer when 263 invasive breast carcinomas were tested for nuclear p53 accumulation in formaldehyde-fixed paraffin sections. Nuclear p53 accumulation was found in > 10% of tumor cells in 61% of medullary carcinomas (22/36), 37% of grade 3 ductal not otherwise specified carcinomas (32/86), 4% of lobular carcinomas (2/47), and 0% (0/7) of mucinous carcinomas. Strong cytoplasmic p53 staining was noted in 32% of lobular carcinomas. High percentages of medullary and high-grade ductal breast carcinomas accumulate nuclear p53, but these tumors have favorable and poor prognoses, respectively. Thus, whereas nuclear p53 accumulation can be associated in these tumors with high morphological malignancy grades in general and with tumor cell proliferation in particular, p53 accumulation is not necessarily correlated with biological aggressiveness. Overall incidence of p53-positive tumors in a particular series of breast carcinomas (in our study 28%) will depend on the ratio of ductal not otherwise specified, medullary, and lobular carcinomas.

摘要

在对263例浸润性乳腺癌的甲醛固定石蜡切片进行核p53积聚检测时,发现不同组织学类型的乳腺癌之间存在显著差异。在61%的髓样癌(22/36)、37%的未另行规定的3级导管癌(32/86)、4%的小叶癌(2/47)和0%的黏液癌(0/7)中,发现>10%的肿瘤细胞存在核p53积聚。在32%的小叶癌中观察到强细胞质p53染色。髓样癌和高级别导管癌中核p53积聚的比例较高,但这些肿瘤的预后分别较好和较差。因此,虽然在这些肿瘤中,核p53积聚一般与高形态学恶性程度相关,特别是与肿瘤细胞增殖相关,但p53积聚不一定与生物学侵袭性相关。特定系列乳腺癌中p53阳性肿瘤的总体发生率(在我们的研究中为28%)将取决于未另行规定的导管癌、髓样癌和小叶癌的比例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f380/1886797/4e010920f58b/amjpathol00075-0017-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f380/1886797/4e010920f58b/amjpathol00075-0017-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f380/1886797/4e010920f58b/amjpathol00075-0017-a.jpg

相似文献

1
Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.核p53蛋白优先在髓样和高级别导管性乳腺癌中积累,但在小叶性乳腺癌中很少积累。
Am J Pathol. 1993 Mar;142(3):669-74.
2
Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.波形蛋白在高级别导管癌和髓样癌中优先表达,但在小叶乳腺癌中不表达。
Am J Pathol. 1990 Nov;137(5):1059-64.
3
p53 mutations and histological type of invasive breast carcinoma.p53突变与浸润性乳腺癌的组织学类型
Cancer Res. 1993 Oct 1;53(19):4665-9.
4
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
5
Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.细胞周期调节蛋白在乳腺导管癌和小叶癌中的异常表达。
Mod Pathol. 2000 Sep;13(9):945-53. doi: 10.1038/modpathol.3880172.
6
Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.乳腺癌中E-钙黏蛋白表达与分化程度及组织学类型的相关性
Am J Pathol. 1993 Apr;142(4):987-93.
7
High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.高核级别、频繁的有丝分裂活性、细胞周期蛋白D1和p53过表达与乳腺囊内乳头状癌的间质浸润相关。
Breast J. 2005 Jan-Feb;11(1):2-8. doi: 10.1111/j.1075-122X.2005.21533.x.
8
Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.细胞周期蛋白D1在原发性乳腺癌中的表达与扩增:与组织病理学类型及临床病理参数的关系
Oncol Rep. 2002 Mar-Apr;9(2):409-16.
9
Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.凋亡相关bcl-2和p53癌蛋白的表达与乳腺癌发生发展的相关性
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2329-35.
10
Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.乳腺导管癌的形态学、增殖指数与癌基因激活的相关性:核分级、S期、增殖细胞核抗原、p53、表皮生长因子受体及c-erb-B-2
Mod Pathol. 1995 Aug;8(6):637-42.

引用本文的文献

1
Biological indices in the assessment of breast cancer.评估乳腺癌的生物学指标。
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
2
Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study.激素替代疗法患者发生的乳腺癌:一项组织学和免疫组织学研究。
J Clin Pathol. 1998 Dec;51(12):935-8. doi: 10.1136/jcp.51.12.935.
3
H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
The cellular protein p53 in human tumours.人类肿瘤中的细胞蛋白p53。
Mol Biol Med. 1984 Aug;2(4):261-72.
3
Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas.波形蛋白和p53在表皮生长因子受体阳性、雌激素受体阴性乳腺癌中的表达
乳腺腺癌基质细胞中H19的过表达与肿瘤值和类固醇受体状态相关,但与p53和Ki-67表达无关。
Am J Pathol. 1998 Nov;153(5):1597-607. doi: 10.1016/S0002-9440(10)65748-3.
4
Prognostic markers for colorectal cancer: expression of P53 and BCL2.结直肠癌的预后标志物:P53和BCL2的表达
World J Surg. 1997 Feb;21(2):210-3. doi: 10.1007/s002689900218.
5
Nuclear image analysis of immunohistochemically stained cells in breast carcinomas.乳腺癌中免疫组织化学染色细胞的核图像分析
Histochem Cell Biol. 1996 Jun;105(6):479-85. doi: 10.1007/BF01457662.
6
Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma.p53蛋白的过表达是人类子宫内膜癌的一个独立预后指标。
Br J Cancer. 1996 Aug;74(4):562-7. doi: 10.1038/bjc.1996.401.
7
Is mucinous carcinoma of the colorectum a distinct genetic entity?结直肠黏液腺癌是一种独特的基因实体吗?
Br J Cancer. 1995 Dec;72(6):1350-6. doi: 10.1038/bjc.1995.514.
8
Expression of p53 oncoprotein in different histological types of breast carcinoma.p53癌蛋白在不同组织学类型乳腺癌中的表达
Am J Pathol. 1994 Jan;144(1):205.
9
Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive.乳腺浸润性小叶癌的免疫组化特征:波形蛋白和p53蛋白主要呈阴性,组织蛋白酶D和雌激素受体呈阳性。
Virchows Arch A Pathol Anat Histopathol. 1993;423(6):497-502. doi: 10.1007/BF01606541.
10
Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.p53肿瘤抑制基因的改变独立于K-ras激活而发生,并且在浆液性腺癌中比在人类卵巢的其他常见上皮性肿瘤中更频繁出现。
Jpn J Cancer Res. 1994 Dec;85(12):1247-56. doi: 10.1111/j.1349-7006.1994.tb02937.x.
Br J Cancer. 1988 Apr;57(4):353-7. doi: 10.1038/bjc.1988.81.
4
P53 expression in breast cancer.乳腺癌中的P53表达
Int J Cancer. 1988 Feb 15;41(2):178-83. doi: 10.1002/ijc.2910410204.
5
Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies.通过与单克隆抗体相互作用揭示的腺病毒5型E1B蛋白在转化细胞中的定位。
Virology. 1985 Apr 15;142(1):44-58. doi: 10.1016/0042-6822(85)90421-0.
6
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.通过p53进行转化的激活突变产生一种基因产物,该产物形成一种半衰期改变的hsc70-p53复合物。
Mol Cell Biol. 1988 Feb;8(2):531-9. doi: 10.1128/mcb.8.2.531-539.1988.
7
Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells.突变型p53蛋白在SV40转化的猴细胞中与hsp 72/73细胞热休克相关蛋白结合。
Oncogene. 1987 May;1(2):201-11.
8
Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.p53肿瘤抑制因子在人乳腺组织、原位肿瘤及体外肿瘤中的表达模式。
Int J Cancer. 1990 Nov 15;46(5):839-44. doi: 10.1002/ijc.2910460515.
9
Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.波形蛋白在高级别导管癌和髓样癌中优先表达,但在小叶乳腺癌中不表达。
Am J Pathol. 1990 Nov;137(5):1059-64.
10
p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.人乳腺癌中p53表达与生存及预后因素的关系:一项免疫组织化学研究
J Pathol. 1991 May;164(1):75-81. doi: 10.1002/path.1711640113.